August 15, 2025Journal of Digestive EndoscopyOpen Access

Clinical Outcomes and Predictors of Early Adverse Events in Primary EUS-Guided Choledochoduodenostomy for Malignant Distal Biliary Obstruction

View Full Paper

Ask AI

Bookmark

Early adverse events occurred in 4.9% of patients undergoing EUS-guided choledochoduodenostomy for biliary obstruction, indicating the procedure's relative safety.
Among 164 eligible patients, the technical success rate of EUS-CDS was 97.0%, while the clinical success rate was 97.5%, demonstrating high efficacy.
Multivariate analysis revealed scope type as an independent risk factor for early adverse events, with an odds ratio of 5.153.
Proper patient selection and device modifications may enhance the safety and feasibility of EUS-guided choledochoduodenostomy, supporting its use in clinical practice.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective analysis shows 97% technical success in EUS-guided choledochoduodenostomy for malignant biliary obstruction, indicating scope type influences early adverse events.

Cite This Study

Okuno et al. (2025) studied this question.

synapsesocial.com/papers/68c235ccb210217d64772573 https://doi.org/10.1055/s-0045-1810606

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis shows 97% technical success in EUS-guided choledochoduodenostomy for malignant biliary obstruction, indicating scope type influences early adverse events.

Clinical Outcomes and Predictors of Early Adverse Events in Primary EUS-Guided Choledochoduodenostomy for Malignant Distal Biliary Obstruction

Key Points

Discussion

Implication

Cite This Study

Clinical Outcomes and Predictors of Early Adverse Events in Primary EUS-Guided Choledochoduodenostomy for Malignant Distal Biliary Obstruction

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading